Back to Authors

Lee, Byung

Mayo Clinic

NeoImmuneTech, Inc. (United States)

Citations 1

624 A phase I/II study evaluating the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy
Butt, Omar H. , Yu, Tao , Luo, Jingquin, Abraham, Christopher , Katumba, Ruth , Yang, Se Hwan, Ansstas, George , Johanns, Tanner M. , Chheda, Milan G. , Campian, Jian , Huang, Jiayi , Zhou, Alice Y. , Lee, Byung, Rettig, Michael P.

Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A656-A656

10.1136/jitc-2022-sitc2022.0624 Get It